Evaluation of serum progesterone level on the day of embryo transfer in frozen cycle at cleavage stage on pregnancy outcomes in two routes of luteal phase support in infertile women refereed to Infertility center affiliated to Hormozgan University of Medical Sciences : A randomized clinical trial study
Phase 3
- Conditions
- Infertility.
- Registration Number
- IRCT20200905048630N2
- Lead Sponsor
- Bandare-abbas University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
ICSI/FET cycles
Having 2-3 high quality embryo
Patients with normal uterine cavity
Infertile women between 18-37 years
Artificial Endometrial preparing
Exclusion Criteria
RIF patients
Aged over 37 years
Patients with a history of recurrent miscarriage, implantation problem
Patients with uterine abnormality like Fibroma, uterine anatomical problems, Polyp, intramural Myoma greater than 4 cm, salpangitis
Patients with grade 3 or 4 endometriosis
Body mass index higher than 30 kg / m2
Patients using two types of progesterone to support the luteal phase
Patients with blastocyst transfer (fifth day embryo)
Ectopic pregnancy
Patients with endometrial thickness less than 7 mm after hormone therapy
Poor quality embryo
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemical pregnancy. Timepoint: 14 days after FET. Method of measurement: beta serum level evaluation.;Clinical pregnancy. Timepoint: 6 week after FET. Method of measurement: Sonography.
- Secondary Outcome Measures
Name Time Method